Total Payments
$74,347
2024 Payments
$1,193
Companies
39
Transactions
645
Medicare Patients
7,076
Medicare Billing
$497,703
Payment Breakdown by Category
Other$51,921 (69.8%)
Food & Beverage$11,977 (16.1%)
Consulting$6,710 (9.0%)
Travel$3,656 (4.9%)
Education$83.10 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $40,681 | 20 | 54.7% |
| Food and Beverage | $11,977 | 601 | 16.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,240 | 6 | 15.1% |
| Consulting Fee | $6,710 | 2 | 9.0% |
| Travel and Lodging | $3,656 | 12 | 4.9% |
| Education | $83.10 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $47,889 | 81 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $11,533 | 67 | $0 (2024) |
| Akcea Therapeutics, Inc. | $5,863 | 12 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $1,929 | 114 | $0 (2024) |
| Amgen Inc. | $750.22 | 46 | $0 (2022) |
| PFIZER INC. | $563.38 | 38 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $554.54 | 36 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $480.47 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $446.07 | 25 | $0 (2024) |
| Merck Sharp & Dohme LLC | $358.88 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,193 | 43 | Medtronic, Inc. ($227.45) |
| 2023 | $1,168 | 51 | Novartis Pharmaceuticals Corporation ($206.70) |
| 2022 | $908.26 | 35 | Novartis Pharmaceuticals Corporation ($162.07) |
| 2021 | $493.14 | 24 | W. L. Gore & Associates, Inc. ($196.07) |
| 2020 | $6,573 | 44 | Lundbeck LLC ($3,397) |
| 2019 | $14,834 | 151 | Lundbeck LLC ($9,443) |
| 2018 | $15,132 | 138 | Lundbeck LLC ($13,218) |
| 2017 | $34,046 | 159 | Lundbeck LLC ($21,831) |
All Payment Transactions
645 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.67 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/24/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $36.24 | General |
| Category: Stents | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/16/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Renal Denervation System | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: DIABETES | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.06 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/07/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $162.97 | General |
| Category: Renal Denervation System | ||||||
| 09/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | ONGLYZA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $87.99 | General |
| Category: NEUROLOGY | ||||||
| 09/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.74 | General |
| Category: Cardiovascular | ||||||
| 08/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.33 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/13/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $33.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: DIABETES | ||||||
| 07/29/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 07/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.81 | General |
| Category: Cardiovascular | ||||||
| 07/16/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $110.39 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,526 | 1,844 | $373,695 | $109,133 |
| 2022 | 19 | 1,512 | 1,822 | $330,471 | $116,524 |
| 2021 | 20 | 1,680 | 2,077 | $338,446 | $132,606 |
| 2020 | 23 | 2,358 | 2,930 | $394,517 | $139,441 |
Total Patients
7,076
Total Services
8,673
Medicare Billing
$497,703
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 307 | 407 | $114,588 | $35,436 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 117 | 134 | $51,000 | $16,619 | 32.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 91 | 93 | $42,512 | $12,604 | 29.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 214 | 216 | $50,256 | $11,459 | 22.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 54 | 54 | $26,060 | $8,302 | 31.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 84 | 115 | $20,388 | $7,191 | 35.3% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2023 | 43 | 43 | $16,512 | $4,913 | 29.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 50 | 50 | $12,950 | $2,790 | 21.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 29 | $7,371 | $2,776 | 37.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 216 | 221 | $12,818 | $2,336 | 18.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 98 | 98 | $5,684 | $1,550 | 27.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 36 | 72 | $3,658 | $995.73 | 27.2% |
| 85610 | Blood test, clotting time | Office | 2023 | 51 | 174 | $3,480 | $730.80 | 21.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 55 | 55 | $2,530 | $589.85 | 23.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 29 | 29 | $2,726 | $575.36 | 21.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 18 | 19 | $494.00 | $123.88 | 25.1% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 17 | 17 | $340.00 | $97.07 | 28.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 18 | 18 | $328.00 | $44.10 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 356 | 515 | $119,250 | $43,371 | 36.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 118 | 158 | $49,716 | $20,950 | 42.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 95 | 96 | $39,370 | $14,682 | 37.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 187 | 187 | $30,391 | $9,781 | 32.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 84 | 128 | $19,328 | $7,214 | 37.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 36 | 36 | $15,396 | $5,245 | 34.1% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2022 | 32 | 32 | $12,144 | $3,803 | 31.3% |
About Dr. Howard Snapper, M.D
Dr. Howard Snapper, M.D is a Nuclear Medicine healthcare provider based in Woodstock, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427019165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Snapper, M.D has received a total of $74,347 in payments from pharmaceutical and medical device companies, with $1,193 received in 2024. These payments were reported across 645 transactions from 39 companies. The most common payment nature is "Honoraria" ($40,681).
As a Medicare-enrolled provider, Snapper has provided services to 7,076 Medicare beneficiaries, totaling 8,673 services with total Medicare billing of $497,703. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Medicine
- Other Specialties Cardiovascular Disease
- Location Woodstock, GA
- Active Since 03/31/2006
- Last Updated 12/02/2019
- Taxonomy Code 207U00000X
- Entity Type Individual
- NPI Number 1427019165
Products in Payments
- NORTHERA (Drug) $45,389
- XARELTO (Drug) $11,511
- TEGSEDI (Drug) $3,403
- ENTRESTO (Drug) $1,760
- ELIQUIS (Drug) $730.22
- Corlanor (Drug) $557.84
- PRADAXA (Drug) $351.21
- BRILINTA (Drug) $327.79
- VERQUVO (Drug) $268.89
- Vascepa (Drug) $245.91
- CHANTIX (Drug) $243.10
- ORENITRAM (Drug) $214.24
- LifeVest (Device) $211.49
- JARDIANCE (Drug) $203.33
- UPTRAVI (Drug) $201.26
- GORE CARDIOFORM Septal Occluder (Device) $196.07
- Repatha (Biological) $192.38
- SYMPLICITY G3 (Device) $177.64
- LEQVIO (Drug) $169.31
- AMVUTTRA (Drug) $151.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.